Ovarian cancer hope

|
phenoxodiolWomen with ovarian cancer are being recruited for a world wide drug trial, to boost their chances of survival when chemotherapy has failed.

Nearly 15-hundred Australians this year will be diagnosed with the disease, described as the 'silent killer'.

Phenoxodiol has proved in clinical trials that it is capable of slowing cancer growth by interfering with the mechanisms that allow ovarian cancer cells to stay alive.

The drug drastically reduces the concentration of chemotherapy needed to kill the cell.

Doctors say Phenoxodiol has a 20 to 30 percent success rate on cancers that would not otherwise respond to chemotherapy or other treatments.

Advanced-stage ovarian cancer is one of the most devastating forms of cancer, with half of the women diagnosed with it dying within five years.

source - SkyNews 

Info

Previous entry: Toward Reducing The Toxic Side Effects Of Cancer Chemotherapy

Next entry: ACCC sues over cancer cure claims

Find recent content on the main index or look in the archives to find all content.